🇺🇸 FDA
Pipeline program

ZYTIGA 250 mg tablets, Placebo to match (PTM) AZD5305 film-coated tablets, Saruparib, ZYTIGA 500 mg film-coated tablets

D9727C00001

Phase 3 small_molecule active

Quick answer

ZYTIGA 250 mg tablets, Placebo to match (PTM) AZD5305 film-coated tablets, Saruparib, ZYTIGA 500 mg film-coated tablets for Prostate Cancer is a Phase 3 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).

Program details

Company
AstraZeneca AB
Indication
Prostate Cancer
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials